In some countries, this medicine may only be approved for veterinary use.
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
G03AA11,G03FA13
CAS registry number (Chemical Abstracts Service)
0035189-28-7
Chemical Formula
C23-H31-N-O3
Molecular Weight
369
Therapeutic Categories
Progestin
Contraceptive
Chemical Names
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one oxime acetate (ester) (WHO)
(+)-17-(Acetyloxy)-13-ethyl-17α-ethynylgon-4-en-3-one oxime
(+)-Essigsäure-(13-ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-in-3-onoxim)-20-ylester (IUPAC)
(17α)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
13beta-Ethyl-3-hydroxyimino-18,19-dinor-17α-pregn-4-en-20-yn-17beta-yl acetate (BAN)
17α-acetoxy-13-ethyl-17-ethynylgon-4-en-3-one oxime
18,19-Dinor-17-pregn-4-en-20-yn-3-one, 17-(acetyloxy)13-ethyl-, oxime (17α)-(+)- (USAN)
18,19-Dinorpregn-4-en-20-yn-3-one, 17-(acetyloxy)-13-ethyl-, 3-oxime, (17α)-
Foreign Names
- Norgestimatum (Latin)
- Norgestimat (German)
- Norgestimate (French)
- Norgestimato (Spanish)
Generic Names
- Norgestimate (OS: BAN, DCF, USAN)
- D 138 (IS: Ortho)
- Dexnorgestrel Acetime (IS)
- ORF-10131 (IS)
- RWJ-10131 (IS)
- Norgestimate (PH: Ph. Eur. 6, USP 32, BP 2010)
- Norgestimatum (PH: Ph. Eur. 6)
Brand Names
- Cilest (Norgestimate and Ethinylestradiol)
Cilag, Bulgaria; Codépharma, France; Delphi, Netherlands; Euro, Netherlands; Janssen, Belgium; Janssen, Colombia; Janssen, Costa Rica; Janssen, Germany; Janssen, Dominican Republic; Janssen, Finland; Janssen, Guatemala; Janssen, Honduras; Janssen, Hungary; Janssen, Luxembourg; Janssen, Nicaragua; Janssen, Netherlands; Janssen, Panama; Janssen, Poland; Janssen, El Salvador; Janssen, Vietnam; Janssen-Cilag, Bahrain; Janssen-Cilag, Switzerland; Janssen-Cilag, Denmark; Janssen-Cilag, United Kingdom; Janssen-Cilag, Lithuania; Janssen-Cilag, Malta; Janssen-Cilag, Oman; Janssen-Cilag, Sweden; Janssen-Cilag, South Africa; Johnson & Johnson, Estonia; Johnson & Johnson, Croatia (Hrvatska); Johnson & Johnson, Latvia; Johnson & Johnson, Slovenia; Johnson & Johnson, Slovakia; Medcor, Netherlands - Cilest 28 (Norgestimate and Ethinylestradiol)
Janssen-Cilag, Sweden - Cileste (Norgestimate and Ethinylestradiol)
Eurim, Austria; Janssen-Cilag, Austria - Crestar (veterinary use)
Intervet, France - Cyclen (Norgestimate and Ethinylestradiol)
Janssen-Ortho Inc., Canada - Edelsin (Norgestimate and Ethinylestradiol)
Effik, Spain - Mononessa (Norgestimate and Ethinylestradiol)
Watson, United States - Norgestimate and Ethinyl Estradiol (Norgestimate and Ethinylestradiol)
Watson, United States - Ortho Tri-Cyclen (Norgestimate and Ethinylestradiol)
Janssen-Ortho Inc., Canada; Ortho-McNeil, United States - Ortho-Cyclen (Norgestimate and Ethinylestradiol)
Ortho-McNeil, United States - Ortrel (Norgestimate and Ethinylestradiol)
Janssen, Venezuela - Pramino (Norgestimate and Ethinylestradiol)
Janssen, Czech Republic; Janssen, Germany - Prefest (Norgestimate and Ethinylestradiol)
Duramed, United States - Previfem (Norgestimate and Ethinylestradiol)
Vintage, United States - Taortho Cyclen-21 (Norgestimate and Ethinylestradiol)
Ortho-McNeil, United States - Triafemi (Norgestimate and Ethinylestradiol)
Effik, France - Tricilest (Norgestimate and Ethinylestradiol)
Codépharma, France; Janssen-Cilag, Austria; Janssen-Cilag, South Africa - Trinessa (Norgestimate and Ethinylestradiol)
Watson, United States - Tri-Sprintec (Norgestimate and Ethinylestradiol)
Teva USA, United States - Vivelle (Norgestimate and Ethinylestradiol)
Janssen-Cilag, Austria
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
IUPAC | International Union of Pure and Applied Chemistry |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment